Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
LGND
Stock Latest News
Market News
Top 5 Trending Stocks by Unusual Trading Volume, 1/14/26
17d ago
LHX
IRTC
Premium
Company Announcements
Ligand Pharma Highlights Broad Disclosure of Athira Investment
1M ago
8K
LGND
Premium
Ratings
Promising Developments and Revenue Prospects Reinforce Buy Rating for Ligand Pharma
2M ago
LGND
Premium
Ratings
Ligand Pharma’s Strong Financial Outlook and Strategic Investments Justify Buy Rating
2M ago
LGND
Premium
The Fly
Ligand price target raised to $230 from $220 at Stifel
2M ago
LGND
Premium
Ratings
Strong Business Model and Growth Potential Drive Buy Rating for Ligand Pharma
2M ago
LGND
Premium
The Fly
Ligand management to meet with Craig-Hallum
2M ago
LGND
Premium
The Fly
Ligand sees FY26 core adjusted EPS view $8.00-$9.00, consensus $7.97
2M ago
LGND
Premium
The Fly
Ligand provides updated five-year outlook
2M ago
LGND
Premium
The Fly
Ligand to host 2025 Investor Day
2M ago
LGND
Premium
The Fly
Ligand reiterates 2025 core adjusted EPS view $7.40-$7.65, consensus $7.62
2M ago
LGND
Premium
Ratings
Ligand Pharma’s Strategic Positioning and Growth Prospects Justify Buy Rating
2M ago
LGND
Premium
The Fly
Ligand initiated with a Buy at Citi
2M ago
LGND
TVTX
Premium
The Fly
Ligand management to meet virtually with Oppenheimer
2M ago
LGND
Premium
Company Announcements
Ligand Pharmaceuticals’ Earnings Call Highlights Strong Growth
3M ago
LGND
Premium
The Fly
Ligand price target raised to $234 from $185 at RBC Capital
3M ago
LGND
Premium
The Fly
Ligand price target raised to $220 from $195 at Stifel
3M ago
LGND
Premium
The Fly
Ligand price target raised to $220 from $175 at Benchmark
3M ago
LGND
Premium
The Fly
Ligand price target raised to $275 from $250 at Oppenheimer
3M ago
LGND
Premium
The Fly
Pelthos Therapeutics acquires Xepi Cream from Biofrontera, Ferrer
3M ago
BFRI
LGND
Premium
Company Announcements
Ligand Pharmaceuticals Reports Strong Q3 Results and Raises Guidance
3M ago
LGND
Premium
The Fly
Ligand price target raised to $231 from $206 at H.C. Wainwright
3M ago
LGND
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
